Items where Author is "Arasteh, K."

2013

Zeuzem, S. and Asselah, T. and Angus, P. and Zarski, J. P. and Larrey, D. and Mullhaupt, B. and Gane, E. and Schuchmann, M. and Lohse, A. W. and Pol, S. and Bronowicki, J. P. and Roberts, S. and Arasteh, K. and Zoulim, F. and Heim, M. and Stern, J. O. and Nehmiz, G. and Kukolj, G. and Bocher, W. O. and Mensa, F. J.. (2013) Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1 : SOUND-C1 final results. Antiviral therapy, Vol. 18, H. 8. pp. 1015-1019.

2012

Larrey, D. and Lohse, A. W. and de Ledinghen, V. and Trepo, C. and Gerlach, T. and Zarski, J. P. and Tran, A. and Mathurin, P. and Thimme, R. and Arasteh, K. and Trautwein, C. and Cerny, A. and Dikopoulos, N. and Schuchmann, M. and Heim, M. H. and Gerken, G. and Stern, J. O. and Wu, K. and Abdallah, N. and Girlich, B. and Scherer, J. and Berger, F. and Marquis, M. and Kukolj, G. and Bocher, W. and Steffgen, J.. (2012) Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. Journal of hepatology, Vol. 57, H. 1. pp. 39-46.

2011

Zeuzem, S. and Asselah, T. and Angus, P. and Zarski, J. P. and Larrey, D. and Mullhaupt, B. and Gane, E. and Schuchmann, M. and Lohse, A. and Pol, S. and Bronowicki, J. P. and Roberts, S. and Arasteh, K. and Zoulim, F. and Heim, M. and Stern, J. O. and Kukolj, G. and Nehmiz, G. and Haefner, C. and Boecher, W. O.. (2011) Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection. Gastroenterology, Vol. 141, H. 6. pp. 2047-2055.